Literature DB >> 17001034

Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.

James S Butler1, Stewart N Loh.   

Abstract

p53 modulates a large number of cellular response pathways and is critical for the prevention of cancer. Wild-type p53, as well as tumorigenic mutants, exhibits the singular property of spontaneously losing DNA binding activity at 37 degrees C. To understand the molecular basis for this effect, we examine the folding mechanism of the p53 DNA binding domain (DBD) at elevated temperatures. Folding kinetics do not change appreciably from 5 degrees C to 35 degrees C. DBD therefore folds by the same two-channel mechanism at physiological temperature as it does at 10 degrees C. Unfolding rates, however, accelerate by 10,000-fold. Elevated temperatures thus dramatically increase the frequency of cycling between folded and unfolded states. The results suggest that function is lost because a fraction of molecules become trapped in misfolded conformations with each folding-unfolding cycle. In addition, at 37 degrees C, the equilibrium stabilities of the off-pathway species are predicted to rival that of the native state, particularly in the case of destabilized mutants. We propose that it is the presence of these misfolded species, which can aggregate in vitro and may be degraded in the cell, that leads to p53 inactivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001034      PMCID: PMC2242404          DOI: 10.1110/ps.062324206

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Pharmacological rescue of mutant p53 conformation and function.

Authors:  B A Foster; H A Coffey; M J Morin; F Rastinejad
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

2.  CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.

Authors:  Stefan Rudiger; Stefan M V Freund; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

3.  p53 contains large unstructured regions in its native state.

Authors:  Stefan Bell; Christian Klein; Lin Müller; Silke Hansen; Johannes Buchner
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

4.  Kinetic partitioning during folding of the p53 DNA binding domain.

Authors:  James S Butler; Stewart N Loh
Journal:  J Mol Biol       Date:  2005-07-29       Impact factor: 5.469

5.  The IARC TP53 database: new online mutation analysis and recommendations to users.

Authors:  Magali Olivier; Ros Eeles; Monica Hollstein; Mohammed A Khan; Curtis C Harris; Pierre Hainaut
Journal:  Hum Mutat       Date:  2002-06       Impact factor: 4.878

6.  Characterization of the p53-rescue drug CP-31398 in vitro and in living cells.

Authors:  Thomas M Rippin; Vladimir J N Bykov; Stefan M V Freund; Galina Selivanova; Klas G Wiman; Alan R Fersht
Journal:  Oncogene       Date:  2002-03-28       Impact factor: 9.867

7.  The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.

Authors:  Yvonne Luu; Jason Bush; K-John Cheung; Gang Li
Journal:  Exp Cell Res       Date:  2002-06-10       Impact factor: 3.905

8.  Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.

Authors:  Wenge Wang; Rishu Takimoto; Farzan Rastinejad; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

9.  Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.

Authors:  James S Butler; Stewart N Loh
Journal:  Biochemistry       Date:  2003-03-04       Impact factor: 3.162

10.  The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.

Authors:  Rishu Takimoto; Wenge Wang; David T Dicker; Farzan Rastinejad; Joseph Lyssikatos; Wafik S el-Deiry
Journal:  Cancer Biol Ther       Date:  2002 Jan-Feb       Impact factor: 4.742

View more
  12 in total

1.  p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis.

Authors:  Saikat Ghosh; Shimul Salot; Shinjinee Sengupta; Ambuja Navalkar; Dhiman Ghosh; Reeba Jacob; Subhadeep Das; Rakesh Kumar; Narendra Nath Jha; Shruti Sahay; Surabhi Mehra; Ganesh M Mohite; Santanu K Ghosh; Mamata Kombrabail; Guruswamy Krishnamoorthy; Pradip Chaudhari; Samir K Maji
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

2.  Most Probable Druggable Pockets in Mutant p53-Arg175His Clusters Extracted from Gaussian Accelerated Molecular Dynamics Simulations.

Authors:  Morad Mustafa; Mohammed Gharaibeh
Journal:  Protein J       Date:  2022-01-31       Impact factor: 2.371

Review 3.  A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.

Authors:  Jessica J Miller; Kalvin Kwan; Christian Gaiddon; Tim Storr
Journal:  J Biol Inorg Chem       Date:  2022-04-30       Impact factor: 3.862

4.  Aggregation of zinc-free p53 is inhibited by Hsp90 but not other chaperones.

Authors:  Huiwen Wu; H Jane Dyson
Journal:  Protein Sci       Date:  2019-09-30       Impact factor: 6.725

5.  Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain.

Authors:  Lucía B Chemes; María G Noval; Ignacio E Sánchez; Gonzalo de Prat-Gay
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

6.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

7.  Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.

Authors:  Eviatar Natan; Cetin Baloglu; Kevin Pagel; Stefan M V Freund; Nina Morgner; Carol V Robinson; Alan R Fersht; Andreas C Joerger
Journal:  J Mol Biol       Date:  2011-03-30       Impact factor: 5.469

8.  Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4.

Authors:  Harish Chander; Max Halpern; Lois Resnick-Silverman; James J Manfredi; Doris Germain
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

9.  Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant.

Authors:  Khaled Barakat; Bilkiss B Issack; Maria Stepanova; Jack Tuszynski
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

Review 10.  Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53.

Authors:  Stewart N Loh
Journal:  Biomolecules       Date:  2020-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.